Latest
Authors at Gynecologic Oncology Meeting Fail to Disclose Industry Relationships
Venous Thromboembolism Risk Steadily Increasing in Cancer
Adherence to Allogeneic Stem Cell Transplantation to Improve Survival in Myelodysplastic Syndromes
Management of AL Amyloidosis, Immunoglobulin Deposition Disease During the COVID-19 Pandemic
Benefits of Hematopoietic Stem Cell Transplantation in Advanced Myelodysplastic Syndromes
FDA Authorizes COVID-19 Test That Provides Rapid Results at Home
Serum Antiphospholipid, Phospholipid-Binding Protein Antibodies in Coronavirus Disease 2019
Conditioning With Alkylating Agents Prior to Transplant for Myelofibrosis
Integrative Medicine Therapies Effectively Increase Quality of Life for Patients With Myeloproliferative Neoplasms
Predictors of Worse Outcomes Identified for Patients With COVID-19 and Myeloma
Toward the Development of Standardized FDG-PET Imaging Criteria to Characterize Response in Multiple Myeloma
Pegcetacoplan Gets Priority Review for Paroxysmal Nocturnal Hemoglobinuria
Featured Content
-
Current Treatment Options for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Investigators summarize current literature surrounding the treatment of NLPHL and discuss treatment considerations for 2 clinical cases. -
Prepare for the End of Pandemic Telehealth Waivers
Healthcare providers should take steps now to ensure that the telehealth modalities they use are HIPAA compliant. -
Treatment of Thrombotic Thrombocytopenic Purpura in Pregnancy
A pair of researchers discuss the treatment and specific clinical challenges associated with thrombotic thrombocytopenic purpura in women who are pregnant. -
Multicenter Study of Spanish Patients Provides New Insights on COVID-19 in Multiple Myeloma
In addition to age, sex, and comorbidities, a new study flagged uncontrolled cancer and renal insufficiency as key prognostic factors for COVID-19 outcomes. -
Polycythemia Vera and Essential Thrombocythemia: Diagnosis, Risk-Stratification, Management Updates
Investigators summarized current literature surrounding the diagnosis and risk-stratification of PV and ET, and reviewed available and upcoming therapies.
-
Loading...
-
Loading...
